Company / Net Income
enGene Holdings Inc. Net Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$117.3M
FY2025
5-year range
-$117.3M / -$24.5M
FY2022-FY2025
Trend
-112.7%
vs FY2024
Sector context
#119 of 215
Health Care
What the data says
At -$117M, enGene Holdings Inc.'s net income ranks #119 of 215 in the Health Care sector. Declined from -$100M to -$117M over the past 2 years.
Based on SEC 10-K filings.
-$117M in FY2025.
Declined from -$100M to -$117M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 215 in Health CareTop 55% of 215This company -$117.3M Sector average $431.3M
▼
-127.2% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 112.7% year-over-year.
- Ranks #119 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$117.3M | -112.7% |
| FY2024 | -$55.1M | +44.8% |
| FY2023 | -$99.9M | -308.5% |
| FY2022 | -$24.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026